Abstract
The emergence of pathogenic fungi resistant to the limited number of available antifungal agents is alarming, representing a significant threat to human health. This urgent scenario highlights the need to develop new antifungal drugs that act on molecular targets capable of reducing the development of resistance and ensuring good therapeutic selectivity. Research in this area therefore em…